Sonic Healthcare Limited operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sonic Healthcare Limited with three other
pharmaceutical manufacturers in Australasia:
Integral Diagnostics Ltd
(2019
sales of 232.39 million Australian Dollars [US$138.49 million]
),
Genetic Technologies Limited
(25,444.00 Australian Dollars [US$15,163.35 ]
of which 100%
was Operations), and
Capitol Health Ltd
(149.24 million Australian Dollars [US$88.94 million]
of which 100%
was Diagnostic Imaging).
Sales Analysis.
Sonic Healthcare Limited reported sales of A$6.13 billion (US$3.66 billion)
for the
fiscal
year ending
June of 2019.
This
represents
an
increase of 10.7%
versus 2018, when the company's sales were A$5.54 billion.
Sales at Sonic Healthcare Limited have increased during each of the previous five years
(and since 2014, sales have increased a total of 57%).
Sales of Laboratory saw an increase
of
9.2% in 2019, from
A$4.57 billion to A$4.99 billion.
Not all segments of Sonic Healthcare Limited experienced an increase in sales in 2019:
sales of Other fell 0.5% to A$438.09 million.